COMMENTARY
Cancer Vaccines 2003: Opening address
Lloyd J. Old
Cancer Immunity 3 Suppl 2 : 1 (12 December 2003) >Full text >PDF

MEETING ABSTRACT
Vaccination and immunological memory
Antonio Lanzavecchia
Cancer Immunity 3 Suppl 2 : 2 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
HIV vaccines: The myth of cross-reactive T cells
Andrew McMichael, Jean Lee, Tao Dong, Guillaume Stewart-Jones, and Yvonne Jones
Cancer Immunity 3 Suppl 2 : 3 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Approaches to the neutralizing antibody problem in HIV vaccine design
Dennis R. Burton
Cancer Immunity 3 Suppl 2 : 4 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
T-cell responses in vaccinated melanoma patients
Thierry Boon, Pierre Coulie, Vaios Karanikas, Christophe Lurquin, Bernard Lethé, Wenbin Ma, and Catherine Germeau
Cancer Immunity 3 Suppl 2 : 5 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Use of monocyte-derived dendritic cells in cancer immunotherapy
Gerold Schuler
Cancer Immunity 3 Suppl 2 : 6 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Toll pathway of host defense
Ruslan Medzhitov
Cancer Immunity 3 Suppl 2 : 7 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
AIDS virus escape from cytotoxic T lymphocyte containment in monkeys
Norman L. Letvin
Cancer Immunity 3 Suppl 2 : 8 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Naturally arising CD25+ CD4+ regulatory T cells in auto-immunity and tumor immunity
Shimon Sakaguchi
Cancer Immunity 3 Suppl 2 : 9 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Approaches to cancer immunotherapy based on breaking tolerance to non-mutated antigens overexpressed on metastatic cancers
Steven A. Rosenberg
Cancer Immunity 3 Suppl 2 : 10 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Engineered T cells as reagents to understand and overcome the limitations of naturally- or vaccine-induced T-cell responses
Philip D. Greenberg, Joseph Blattman, Laurence Cheng, Michelle Dossett, Carla Fowler, Yamina Hamel, William Ho, David Kranz, Adrian Ochsenbein, Claes Ohlen, Max Topp, and Cassian Yee
Cancer Immunity 3 Suppl 2 : 11 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Memory CD8 T-cell differentiation during acute versus chronic viral infection
Rafi Ahmed
Cancer Immunity 3 Suppl 2 : 12 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Inactivated retroviral virions with functional envelope glycoproteins
Jeffrey D. Lifson
Cancer Immunity 3 Suppl 2 : 13 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Cancer vaccination strategies targeting NY-ESO-1
Alexander Knuth
Cancer Immunity 3 Suppl 2 : 14 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Naturally occurring immunogenicity of NY-ESO-1 in cancer patients
Sacha Gnjatic
Cancer Immunity 3 Suppl 2 : 15 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Vaccines against NY-ESO-1: Peptides and recombinant viral constructs
Elke Jäger
Cancer Immunity 3 Suppl 2 : 16 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
NY-ESO-1 protein formulated With ISCOMATRIX™ adjuvant induces a broad-based immune response involving high titers of antibody, CD4+ and CD8+ T-cell responses
Jonathan Cebon, Ian D. Davis, Weisan Chen, Heather Jackson, Phillip Parente, Catherine Barrow, Wendie Hopkins, Qiyuan Chen, Roger Murphy, Andrew Scott, Eugene Maraskovsky, Grant McArthur, Duncan MacGregor, Tsin Yee Tai, Nektaria Dimopoulos, Simon Green, Andrew Cuthbertson, Darryl Maher, Lena Miloradovic, Sue Mitchell, Gerd Ritter, Elisabeth Stockert, Lisa Pugliese, Eric W. Hoffman, and Lloyd J. Old
Cancer Immunity 3 Suppl 2 : 17 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Heat shock protein receptors: Implications for vaccination
Pramod K. Srivastava
Cancer Immunity 3 Suppl 2 : 18 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Melan-A/MART-1: Immunogenicity and vaccine strategies
Jean-Charles Cerottini, Pedro Romero, and Daniel E. Speiser
Cancer Immunity 3 Suppl 2 : 19 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
Immunodominance of pox-viral specific CTL and the role of NKT cells to induce broad antigen-specific CD4+ and CD8+ T-cell responses: Lessons from pre-clinical and clinical studies
Vincenzo Cerundolo
Cancer Immunity 3 Suppl 2 : 20 (12 December 2003) >Abstract >PDF

MEETING ABSTRACT
A potential HIV-1 vaccine based on the elicitation of cellular immune responses
Emilio A. Emini
Cancer Immunity 3 Suppl 2 : 21 (12 December 2003) >Abstract >PDF